Discover the operationalization and use of bispecific T-cell–engaging antibodies in community practices. Learn from multidisciplinary perspectives on establishing workflows to manage patients with cytokine release syndrome: https://t.co/YW9P4oOft3

APP CROSS is a standardized scoring system designed to objectively evaluate advanced practice provider clinical rotation requests in oncology. Discover its objective approach to student selection and effects in enhancing recruitment and retention: https://t.co/XW56GNe9QA #JADPRO

#JADPROLive is the premier CE-accredited event for oncology advanced practitioners. Join the network of your peers in National Harbor, Maryland on Oct. 23 – 26 for the meeting the designed exclusively BY and FOR advanced practitioners. Register: https://t.co/ft7EYqRDvX

The Sept/Oct issue of the JADPRO is LIVE! Read about improved strategies for safe opioid prescribing, an innovative therapy for glioblastoma, and the impact of body image on quality of life in advanced breast cancer patients in this issue of JADPRO: https://t.co/oyoraMML0g

A new study explores the association of team culture, communication, perceived staffing, and work location on team satisfaction in an outpatient hematology and oncology practice at a large academic medical center. Read the study: https://t.co/qUuNg0AFfo #JADPRO

ICYMI: The July/August issue of the JADPRO is LIVE! Discover the impact of federal funding cuts, improved use of outpatient blood products, and a comprehensive approach to advocating for administrative time in this issue of JADPRO: https://t.co/VAi0I9YnVP

Providing 8 hours of weekly administrative time may improve retention and reduce burnout among advanced practitioners, according to new recommendations from APSHO. More here: https://t.co/39AU99QWNX #AdvancedPractice #WorkforceSustainability

A transfusion algorithm improved the appropriate use of CMV-negative and irradiated blood products in an outpatient oncology clinic, supporting safer, standardized care. Details: https://t.co/39AU99QWNX #Oncology #AdvancedPractice

Federal funding cuts have terminated over 2,000 NIH grants and dozens of clinical trials. @Bethfaiman highlights how these changes may affect research, patient care, and the advanced practitioner workforce. 🔗 https://t.co/A1oCjTEE6b #OncologyAP #HealthPolicy

Administrative time is a critical part of effective oncology practice. Explore strategies to secure dedicated time for documentation, professional development, and coordination. ➡️ https://t.co/JDyO6dpFMA #AdvancedPractitioner #OncologyLeadership

A mentorship model pairing oncology APPs with CRCs increased trial enrollment and expanded access in underserved communities. It also enhanced APP engagement in research oversight. 🔗 https://t.co/UmQ6Ry2gJb #OncologyResearch #ClinicalTrials

Track key FDA oncology approvals with clinical context including indication, mechanism, and administration considerations. JADPRO’s FDA Focus offers timely updates relevant to patient care. 🔗 https://t.co/MRHanuSouJ #OncologyEducation #FDAUpdates

🧠 Sharing research findings with patients just got easier. Plain language summaries help advanced practice providers translate data into meaningful conversations. 🔗 https://t.co/EcfYKhwyEt #ClinicalTools #AdvancedPractitioners

What does it take to move #BPDCN patients safely to transplant? #Tagraxofusp offers durable responses and SCT bridging. AP-led monitoring supports safer, more effective outcomes. 🔗 https://t.co/2mSCEy2WEM #OncologyCare #AdvancedPractitioners

Non-mass enhancement on MRI revealed high-grade DCIS nearly a decade before mammographic signs appeared. This case highlights the value of image comparison and modality selection in dense breast screening. 🔗 https://t.co/JnHlM6oUnZ #BreastImaging #AdvancedPractice

Can a structured walking plan help manage cancer-related fatigue in patients on oral therapy? This pilot program explores practical tools for symptom relief and nursing education. 🔗 https://t.co/zl6yrYt1wc #OncologyCare #FatigueManagement

Timely diagnosis of rare diseases remains a major challenge. @Bethfaiman and colleagues share a new AP-developed toolkit to support symptom management in systemic mastocytosis and beyond. Explore more ➡️ https://t.co/aAhUm678YX #RareDisease #AdvancedPractitioner

Advanced insights for APs in oncology. Explore APRN-led support post–Phase I trials, strategies for managing systemic mastocytosis, pharmacist input on talquetamab, and a case of PML after CAR T therapy. Plus, rural barriers to CRC screening & more. 👉 https://t.co/QWrTUK3AOW

Don’t miss the APSHO Annual Member Meeting at JADPRO Live! Wendy Vogel, Executive Director of APSHO, highlights the updates and new initiatives to get involved in as members of APSHO. Register here: https://t.co/ft7EYqRDvX #JADPROLive #APSHO

Lisa A. Kottschade, President of APSHO, wants to see you at JADPRO Live 2025! Join us October 23 - 26 for oncology and hematology education targeted toward higher-level thinking and practical application in patient care. Register today: https://t.co/ft7EYqRDvX #JADPROLive #APSHO